PE20001598A1 - Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina - Google Patents

Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina

Info

Publication number
PE20001598A1
PE20001598A1 PE2000000275A PE0002752000A PE20001598A1 PE 20001598 A1 PE20001598 A1 PE 20001598A1 PE 2000000275 A PE2000000275 A PE 2000000275A PE 0002752000 A PE0002752000 A PE 0002752000A PE 20001598 A1 PE20001598 A1 PE 20001598A1
Authority
PE
Peru
Prior art keywords
benzodioxin
dihydro
derivatives
ethyl
alcoxycarbonylmethyl
Prior art date
Application number
PE2000000275A
Other languages
English (en)
Inventor
Yannick Evanno
Peretti Daniele De
Jean Francois Gibert
Michel Peynot
Maria Carmen Renones
Jocelyne Roy
Garcia Antonio Almario
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PE20001598A1 publication Critical patent/PE20001598A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE N-[2-(4-AMINOFENIL)ETIL]-2,3-DIHIDRO-1,4-BENZODIOXIN-2-METANAMINA DE FORMULA I, DONDE: X ES H, HALOGENO, CIANO, NITRO, OH, ALQUILO C1-C4, FENILO, TIENILO, TIENILMETOXI, ALCOXI C1-C4, CICLOALQUILMETOXI C3-C6, FENILMETOXI, ALCOXICARBONILO C1-C4, ALCOXICARBONILMETILO C1-C4, PIRROLIDIN-1-ILCARBONILO, CARBAMOILO, ENTRE OTROS; R1 ES H, METILO; R2 ES ALCANOILO C1-C4, FENILALCANOILO C1-C4, METOXIACETILO, CICLOALQUILCARBONILO C3-C6, BENZOILO OPCIONALMENTE SUSTITUIDO CON HALOGENO, ALQUILO C1-C4, ALCOXI C1-C4, ENTRE OTROS; NR1R2 ES 2-OXO-4,5-DIHIDROOXAZOLIDIN-3-ILO. LOS COMPUESTOS DE FORMULA I TIENEN AFINIDAD POR LOS RECEPTORES DOPAMINERGICOS DE TIPO D3, AFINIDAD MODERADA DE TIPO D2 Y 5-HT1A Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE PSICOSIS, ESQUIZOFRENIA, ANSIEDAD, PANICO, FOBIAS, TRASTORNOS OBSESIVO COMPULSIVOS
PE2000000275A 1999-03-30 2000-03-30 Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina PE20001598A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903936A FR2791675B1 (fr) 1999-03-30 1999-03-30 Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PE20001598A1 true PE20001598A1 (es) 2001-04-01

Family

ID=9543788

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000275A PE20001598A1 (es) 1999-03-30 2000-03-30 Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina

Country Status (6)

Country Link
AU (1) AU3660700A (es)
CO (1) CO5170535A1 (es)
FR (1) FR2791675B1 (es)
PE (1) PE20001598A1 (es)
UY (1) UY26085A1 (es)
WO (1) WO2000058301A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
PA8663501A1 (es) 2005-02-17 2006-11-09 Wyeth Wyeth Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados
TW200716595A (en) 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
JP2008538575A (ja) * 2005-04-22 2008-10-30 ワイス ベンゾジオキサンおよびベンゾジオキソラン誘導体ならびにそれらの使用
AR060493A1 (es) * 2006-04-18 2008-06-18 Wyeth Corp Derivados de benzodioxano y benzodioxolano. procesos de obtencion.
TW200823187A (en) * 2006-10-24 2008-06-01 Wyeth Corp Benzodioxane derivatives and uses thereof
CA2722986A1 (en) 2008-04-29 2009-11-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
CA2722978A1 (en) 2008-04-29 2009-11-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
EP2271635A1 (en) * 2008-04-29 2011-01-12 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulators of dopamine neurotransmission

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281245A (es) * 1962-07-20
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives

Also Published As

Publication number Publication date
WO2000058301A1 (fr) 2000-10-05
UY26085A1 (es) 2000-10-31
AU3660700A (en) 2000-10-16
CO5170535A1 (es) 2002-06-27
FR2791675A1 (fr) 2000-10-06
FR2791675B1 (fr) 2001-05-04

Similar Documents

Publication Publication Date Title
PE68799A1 (es) Derivados de tetrahidroisoquinolina como moduladores del receptor de d3 de dopamina
PE20001598A1 (es) Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina
PE20040600A1 (es) Derivados de triazol como antagonistas del receptor de taquicinina
PE20001088A1 (es) Compuestos derivados de tetrahidrobenzazepina
PE20061127A1 (es) Derivados de propanosulfonamida que potencian el receptor de glutamato
PE20031011A1 (es) Derivados de dihidrobenzodiazepin-2-ona-iii
PE20060010A1 (es) 2,3,4,5-TETRAHIDRO-1H-BENZO[d]AZEPINAS 6-SUSTITUIDAS COMO AGONISTAS DEL RECEPTOR 5-HT2C
PE20010543A1 (es) Derivados de purina como inhibidores de tirosincinasa syk
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
BR0214455A (pt) Derivados benzotiazol
PE20001483A1 (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos
PE20061318A1 (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos
AR054021A1 (es) Derivados de ciclopentapiridina y tetrahidroquinolina
ES2064973T3 (es) Nuevos derivados de indol.
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
AR054083A1 (es) Compuestos imidazol y su utilizacion paar preparar medicamentos
PE20040907A1 (es) Derivados de anilinopirazol
PE20081504A1 (es) Compuestos de biciclocarboxiamida sustituidos
PE20060196A1 (es) Derivados de indol con actividad androgenica
PE20000467A1 (es) Derivado de indol util como inhibidor de serotonina
PE20020258A1 (es) Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina 1 (nk-1)
PE20020692A1 (es) Compuestos derivados de benzotiofeno y su procedimiento de obtencion
PE106299A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)-1h-indol
PE20030541A1 (es) Compuestos pirimidina de anillo fusionado alquinilado como inhibidores de metaloproteasa de matriz tipo 13
PE20060584A1 (es) Derivados de piridina como antagonistas de receptores de cannabinoides cb1 y procedimiento de preparacion

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed